Home › Merck, Iowa firm sign Ebola vaccine licensing deal
 

Keywords :   


Merck, Iowa firm sign Ebola vaccine licensing deal

2014-11-24 20:15:55| Biotech - Topix.net

Merck & Co., one of the world's top developers and sellers of vaccines, has entered a partnership with a small drug developer to research and manufacture a potential Ebola vaccine now in initial patient testing. The exclusive deal involves a vaccine candidate called rVSV-EBOV that's under early development by BioProtection Systems, the vaccine-development subsidiary of NewLink Genetics Corp. of Ames, Iowa.

Tags: sign deal firm iowa

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
27.09Washington Corner | September 2024
27.09Hurricane Isaac Graphics
27.09Remnants of John Graphics
27.09Remnants of John Forecast Discussion Number 20
27.09Remnants of John Wind Speed Probabilities Number 20
27.09Remnants of John Public Advisory Number 20
27.09Summary for Remnants of John (EP5/EP102024)
27.09Tropical Storm Joyce Graphics
More »